the many problems of its definition and diagnosis to subsequent speakers.
Most hypertension is not associated with any of the rare definite etiologies; it is of unknown etiology, and it is called essential. I want to stress the extremely wide range of courses available to patients with untreated essential hypertension. This can be emphasized by indicating the two extremes. Those few patients who have malignant or accelerated hypertension die very quickly of their disease; moreover, their last few months of life are miserable. Only half survive 6 months after the diagnosis has been made. Very nearly all of them die because of failure of some part of their cardiovascular renal systems, and it is the kidney that usually fails first.
The situation is very different for those patients with the mildest types of hypertension, those who have only transient and not very marked elevations of diastolic pressure and who have no demonstrable cardiac or renal damage. By and large, such patients live for a long time, perhaps for 20 years on the average; moreover, they are usually well for by far the largest part of this 20 years.
When they finally die, they tend to die of causes unrelated to cardiovascular renal disease, such as pneumonia and the automobile. Those who succumb to their cardiovascular renal disease, succumb to conditions such as strokes and myocardial infarction. These complications are not primarily hypertensive, rath-er, they are arteriosclerotic.
Hypertension and arteriosclerosis represent different pathologic processes. Hypertension does not produce arterioselerosis, but it does augment its rate of progression. The very frequent association of the two diseases makes it difficult to separate them clinically. Effective antihypertensive therapy is now available. Whether such therapy is antiarterioselerotic remains to be seen. At present there is no good evidence that it is. Obviously antihypertensive therapy is mandatory for a severely hypertensive patient who is almost certainly going to die of his hypertension, and in the near future. The rationale for such therapy is much less obvious in a mildly hypertensive patient who is probably going to live for decades and who is most likely to die of eonditions that are unrelated to his hypertension. In fact, it seems is superfluous. It is obvious that the major abuse of drugs is to treat when we should not treat. I was particularly startled some years ago when I was asked to see an 84-year-old lady who was being treated for hypertension. The poor lady had a blood pressure of 180/ 110 before treatment, and as a result of antihypertensive treatmenit she was completely bedridden, and all she wanted to do, of all Circulation, Volume XXVIII, October 1963 things, was go to Atlantic City. As soon as we stopped treating her, she was able to achieve her desire, went to Atlantic City, and lived for the next 4 or 5 years very happily. She died of some other eause, as Dr. Perry has suggested. This was obviously a flagrant abuse of drugs.
It is almost unfortunate in some respects that we have so many potent drugs that will effectively lower blood pressure. We also have very potent drugs to rid the body of sodium, but this is perhaps a little less unfortunate. For nearly 60 years, it has been known that if a patient avoided salt, and was maintained on a very low salt regime, the blood pressure would generally decrease. Sepulchretum (1679) , collected a number of observations on palpitation and cardiac pain during life associated with polvpi in the heart, calculi in the myocardium, inflammation of the heart, acute inflammation, effusion and adhesion of the pericardium, and aortic aneurysm, and thus prepared the way for Morgagni and others.
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